Unilateral nevoid telangiectasia
| Unilateral nevoid telangiectasia | |
|---|---|
| Synonyms | Unilateral nevoid telangiectasia syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Telangiectasia on one side of the body |
| Complications | N/A |
| Onset | Usually during puberty or pregnancy |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, possibly related to hormonal changes |
| Risks | Hormonal changes, genetic predisposition |
| Diagnosis | Clinical diagnosis |
| Differential diagnosis | Port-wine stain, Spider angioma, Hereditary hemorrhagic telangiectasia |
| Prevention | N/A |
| Treatment | Laser therapy, Sclerotherapy |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | N/A |
Unilateral nevoid telangiectasia (UNT) is a rare dermatological condition characterized by the presence of telangiectasia on one side of the body. It was first described by William James Blaschko in 1899.
Overview[edit]
Unilateral nevoid telangiectasia is a benign skin condition that typically presents as a unilateral distribution of linear or patchy telangiectasias. The condition can be congenital or acquired, with the acquired form often associated with hormonal changes or systemic diseases such as liver cirrhosis or pregnancy.
Symptoms[edit]
The primary symptom of UNT is the appearance of red, dilated blood vessels (telangiectasias) on the skin. These can appear anywhere on the body but are most commonly found on the neck, chest, and arms. The telangiectasias are usually asymptomatic, but some patients may experience mild itching or burning.
Diagnosis[edit]
Diagnosis of UNT is primarily based on clinical examination. A dermatoscope may be used to visualize the telangiectasias more clearly. In some cases, a skin biopsy may be performed to rule out other conditions.
Treatment[edit]
There is currently no cure for UNT, but treatments are available to manage the symptoms. These may include laser therapy, topical creams, or oral medications. In some cases, the telangiectasias may fade on their own over time.
Epidemiology[edit]
UNT is a rare condition, with fewer than 100 cases reported in the medical literature. It affects both men and women, but is more common in women, possibly due to hormonal influences.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian